SCHEMBL3430815

SCHEMBL3430815

CC1CCCC(C(=O)N2CCN(c3cccnn3)CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.47
RIPK1 Q13546 1/20 0.46
TRPV1 Q8NER1 2/20 0.46
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
GRM5 P41594 3/20 0.41
IDH1 O75874 1/20 0.41
HTT P42858 1/20 0.41
NAMPT P43490 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
GBA1 P04062 1/20 0.40
GRM1 Q13255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3430814 1.00 SLC6A7 (0.47) SLC6A7RIPK1TRPV1ALDH1A1KMT2A
SCHEMBL3434053 0.85 RIPK1 (0.52) SLC6A7RIPK1TRPV1ALDH1A1KMT2A
SCHEMBL938852 0.81 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL5317665 0.80 SLC6A7 (0.53) SLC6A7RIPK1TRPV1KDM4EHTT
SCHEMBL5317667 0.80 SLC6A7 (0.53) SLC6A7RIPK1TRPV1KDM4EHTT
SCHEMBL3433327 0.79 SLC6A7 (0.49) SLC6A7RIPK1TRPV1ALDH1A1KDM4E
SCHEMBL3433329 0.79 SLC6A7 (0.49) SLC6A7RIPK1TRPV1ALDH1A1KDM4E
SCHEMBL3210375 0.75 GAA (0.57) TRPV1ALDH1A1NPSR1
SCHEMBL27702525 0.74 SLC6A7 (0.63) SLC6A7RIPK1TRPV1ALDH1A1KMT2A
SCHEMBL1380775 0.73 SCD (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257291-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS Xenon Pharmaceuticals Inc. (CA) 2010-12-08 EP disclosed
WO-2009106991-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2009-09-03 WO disclosed
EP-1851205-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2007-11-07 EP disclosed
WO-2006086447-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2006-08-17 WO disclosed